Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Trek Diagnostic Systems, Ltd. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

83 daysmedian FDA review time
205 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K110583SENSITITRE OPTIREADTrek Diagnostic Systems, Ltd.2011-09-222050
K111429SENSITITRE (R) HP MIC SUSCEPTIBILITY PLATE WITH CEFAROLINE (Trek Diagnostic Systems, Ltd.2011-08-18871
K110331SENSITITRE AIM (TM)Trek Diagnostic Systems, Ltd.2011-04-27830
K093741SENSITIVE HAEMOPHILUS INFLUENZAE, STREPTOCOCCUS PNEUMONIA, (Trek Diagnostic Systems, Ltd.2010-02-25830
K092445SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATESTrek Diagnostic Systems, Ltd.2009-12-161280
K062681SENSITITRE HAEMOPHILUS/STREPTOCOCCUS PNEUMONIAE (HP) MIC PLATrek Diagnostic Systems, Ltd.2006-10-13350
K041534SENSITITRE HAEMOPHILUS/STREPTOCOCCUS PNEUMONIAE (HP) MIC SUSTrek Diagnostic Systems, Ltd.2004-07-27490

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda